Physician profile
Abdulrasheed Alabi
NPI 1013364371
$31,713.97
in general payments reported to CMS, 2019-2025
5 companies · $5,460 in 2025
The $5,460 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.00 · 2022: $75.00 · 2023: $13K · 2024: $13K · 2025: $5,460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $26K · Travel and Lodging: $4,408 · Food and Beverage: $857 · Education: $483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $25,791.66 |
| Travel and Lodging | $4,407.87 |
| Food and Beverage | $857.35 |
| Education | $483.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $15,856.64 | 2023-2025 | Aveir |
| Medtronic, INC. | $9,017.47 | 2023-2025 | Micra |
| Boston Scientific Corporation | $5,000.00 | 2023-2024 | |
| Biotronik INC. | $1,665.86 | 2025 | Amvia Edge, Acticor 7 Vr-T Dx |
| Astellas Pharma US INC | $174.00 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdulrasheed Alabi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.